From GlobeNewswire: 2024-05-29 14:00:00

The Global Nasal Cannula Market is projected to grow from USD 7.95 billion in 2023 to USD 14.82 billion by 2033, with a CAGR of 6.43% during the forecast period. Nasal cannulas deliver oxygen to patients through the nose, vital for those with respiratory issues like asthma and COPD. The market is driven by the increasing elderly population and the rising demand for oxygen therapy. However, long-term use of nasal cannulas can lead to severe side effects that may restrain market growth. The low-flow segment dominates the market, providing controlled amounts of oxygen to patients with respiratory disorders. Plastic nasal cannulas are the preferred choice due to affordability and comfortable use. Hospitals are the largest end-user of nasal cannulas, particularly for high-flow therapy for severe respiratory issues. North America leads the market due to high rates of respiratory illnesses and advanced healthcare facilities. Asia-Pacific is expected to grow rapidly, fueled by increasing healthcare spending and demand for home healthcare solutions. Major players in the market include ResMed Inc., Teleflex Incorporated, Fisher & Paykel Healthcare Limited, and others. Smiths Medical recently launched its new OptiflowTM 5 HFNC system for both geriatric and pediatric patients. The global nasal cannula market is segmented by type, material, end-user, and region, with comprehensive forecasts up to 2033. Other related reports focus on topics like electrical stimulators, AI in healthcare, chronic wound care, and human microchipping. Spherical Insights & Consulting provides actionable research and trend analysis for decision-makers in various industries.



Read more at GlobeNewswire: Global Nasal Cannula Market Size To Exceed USD 14.82